Updated Efficacy And Safety Of Patritumab Deruxtecan (Her3-Dxd; U3-1402), A Her3 Directed Antibody Drug Conjugate, In Egfrm Nsclc

ANNALS OF ONCOLOGY(2021)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要